|
95 Companies |
|
180 Products |
|
180 Products |
|
97 Mechanisms of Action |
|
2 Trials |
|
2111 News |
|
| 12345678910111213...4243» |
- Phase classification, HEOR, Surgery: CHEC: Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis (clinicaltrials.gov) - Jul 10, 2024
P=N/A, N=25, Terminated, Sponsor: Integra LifeSciences Corporation
Phase classification: P4 --> P=N/A
- | Enrollment change, Trial withdrawal: Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children (clinicaltrials.gov) - Mar 21, 2024
P1, N=0, Withdrawn, Sponsor: Aryn Knight
Phase classification: P4 --> P=N/A N=10 --> 0 | Suspended --> Withdrawn
- | NN1213 / Novo Nordisk
Trial withdrawal: Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus (clinicaltrials.gov) - May 1, 2019
P=N/A, N=0, Withdrawn, Sponsor: University of Minnesota - Clinical and Translational Science Institute
N=10 --> 0 | Suspended --> Withdrawn Completed --> Withdrawn
- | acetylcysteine solution / Generic mfg.
Trial completion, Trial completion date: Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy (clinicaltrials.gov) - Apr 30, 2019
P2, N=34, Completed, Sponsor: Mayo Clinic
Completed --> Withdrawn Active, not recruiting --> Completed | Trial completion date: May 2019 --> Jul 2018
- | Trial completion, Enrollment change: An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=41, Completed, Sponsor: Virginia Commonwealth University
Active, not recruiting --> Completed | Trial completion date: May 2019 --> Jul 2018 Active, not recruiting --> Completed | N=62 --> 41
- | Trial completion date: An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=62, Active, not recruiting, Sponsor: Virginia Commonwealth University
Active, not recruiting --> Completed | N=62 --> 41 Trial completion date: Mar 2019 --> Jun 2019
- | TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
Trial completion, Enrollment change, Metastases: Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC (clinicaltrials.gov) - Apr 20, 2019
P3, N=160, Completed, Sponsor: Fudan University
Trial completion date: Mar 2019 --> Jun 2019 Recruiting --> Completed | N=320 --> 160
- | NN1213 / Novo Nordisk
Trial completion: Pilot Study of Deep Brain Stimulation (DBS) in Area LC for Chronic Tinnitus (clinicaltrials.gov) - Apr 20, 2019
P1, N=10, Completed, Sponsor: Paul Larson
Recruiting --> Completed | N=320 --> 160 Active, not recruiting --> Completed
- | acetylcysteine solution / Generic mfg.
Enrollment change, Trial completion date: Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy (clinicaltrials.gov) - Apr 19, 2019
P2, N=34, Active, not recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Completed N=18 --> 34 | Trial completion date: Dec 2018 --> May 2019
- | Trial completion: Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais (clinicaltrials.gov) - Mar 18, 2019
P4, N=84, Completed, Sponsor: Pongsakorn Tantilipikorn
N=18 --> 34 | Trial completion date: Dec 2018 --> May 2019 Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date, Surgery: Randomized Control Trials of Surgery for Pediatric OSA (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=143, Completed, Sponsor: Karolinska University Hospital
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Oct 2026 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019
- ||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, HEOR: Clinical and Health Economic Evaluation With a New Baha (clinicaltrials.gov) - Feb 26, 2019
P=N/A, N=106, Completed, Sponsor: Cochlear Bone Anchored Solutions
Active, not recruiting --> Completed | Trial completion date: Oct 2026 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 Active, not recruiting --> Completed | Trial completion date: Jun 2017 --> Nov 2017
- | Trial completion, Trial completion date, Trial primary completion date: Eustachian Tube Growth and Development (clinicaltrials.gov) - Feb 22, 2019
P=N/A, N=126, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed | Trial completion date: Jun 2017 --> Nov 2017 Active, not recruiting --> Completed | Trial completion date: Jul 2020 --> Aug 2018 | Trial primary completion date: Jul 2020 --> Jan 2017
- | Enrollment closed, Trial completion date: An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms (clinicaltrials.gov) - Feb 19, 2019
P=N/A, N=62, Active, not recruiting, Sponsor: Virginia Commonwealth University
Active, not recruiting --> Completed | Trial completion date: Jul 2020 --> Aug 2018 | Trial primary completion date: Jul 2020 --> Jan 2017 Recruiting --> Active, not recruiting | Trial completion date: Dec 2018 --> Mar 2019
- | NN1213 / Novo Nordisk
Trial completion: Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand (clinicaltrials.gov) - Feb 18, 2019
P=N/A, N=500, Completed, Sponsor: Chulalongkorn University
Recruiting --> Active, not recruiting | Trial completion date: Dec 2018 --> Mar 2019 Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Mini-Mental State (MMS-LS) and Sign Language (clinicaltrials.gov) - Feb 15, 2019
P=N/A, N=195, Completed, Sponsor: Lille Catholic University
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Apr 2018 --> Dec 2017
- | ifosfamide / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Enrollment change: Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma (clinicaltrials.gov) - Feb 11, 2019
P2, N=9, Terminated, Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting --> Completed | Trial completion date: Apr 2018 --> Dec 2017 N=35 --> 9
- | Enrollment change: Effects of a Vestibular Rehabilitation Maneuver (clinicaltrials.gov) - Feb 8, 2019
P=N/A, N=16, Completed, Sponsor: Day General Hospital.
N=35 --> 9 N=23 --> 16
- | Enrollment change, Trial withdrawal: Diesel Exhaust Particles and Leukotriene Production (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=0, Withdrawn, Sponsor: University of California, Los Angeles
N=23 --> 16 N=25 --> 0 | Active, not recruiting --> Withdrawn
- | 5-fluorouracil / Generic mfg., cisplatin / Generic mfg., docetaxel / Generic mfg.
Trial completion date, Trial primary completion date: GORTEC-NPC2006: Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers (clinicaltrials.gov) - Jan 18, 2019
P3, N=83, Terminated, Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
N=25 --> 0 | Active, not recruiting --> Withdrawn Trial completion date: Dec 2017 --> Apr 2017 | Trial primary completion date: Dec 2017 --> Apr 2017
- ||||||| Depigoid Birch (depigmented glutaraldehyde polymerized birch pollen allergenic extract) / Leti Pharma
Trial completion, Trial primary completion date: Depigoid Birch 5000 Longterm Study in Adults and Adolescents (clinicaltrials.gov) - Jan 16, 2019
P3, N=634, Completed, Sponsor: Leti Pharma GmbH
Trial completion date: Dec 2017 --> Apr 2017 | Trial primary completion date: Dec 2017 --> Apr 2017 Active, not recruiting --> Completed | Trial primary completion date: May 2018 --> Jul 2018
- | aspirin / Generic mfg.
Trial completion: High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD) (clinicaltrials.gov) - Jan 16, 2019
P=N/A, N=10, Completed, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed | Trial primary completion date: May 2018 --> Jul 2018 Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: The Efficacy of Steroid Therapy in Vestibular Neuritis (clinicaltrials.gov) - Jan 10, 2019
P3, N=40, Completed, Sponsor: Asan Medical Center
Recruiting --> Completed Active, not recruiting --> Completed | N=60 --> 40
- ||| Trial completion, Enrollment change: Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss (clinicaltrials.gov) - Dec 21, 2018
P1/2, N=31, Completed, Sponsor: Nordmark Arzneimittel GmbH & Co. KG
Active, not recruiting --> Completed | N=60 --> 40 Active, not recruiting --> Completed | N=115 --> 31
- | NN1213 / Novo Nordisk
Trial completion: Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=93, Completed, Sponsor: University Hospital, Toulouse
Active, not recruiting --> Completed | N=115 --> 31 Recruiting --> Completed
- | Trial completion: AUTO-ACUSAR - Effects of Acupuncture on the Autonomic Nervous System in Seasonal Allergic Rhinitis Patients (clinicaltrials.gov) - Nov 20, 2018
P=N/A, N=60, Completed, Sponsor: Charite University, Berlin, Germany
Recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change: BPPV Treatment in Biaxial Rotational Chair (clinicaltrials.gov) - Nov 15, 2018
P=N/A, N=57, Completed, Sponsor: Haukeland University Hospital
Active, not recruiting --> Completed N=170 --> 57
- | acetylcysteine solution / Generic mfg.
Phase classification: Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy (clinicaltrials.gov) - Oct 31, 2018
P2, N=18, Active, not recruiting, Sponsor: Mayo Clinic
N=170 --> 57 Phase classification: P=N/A --> P2
- | Synflorix (10-valent pneumococcal conjugate vaccine) / GSK
Trial completion, Pneumococcal vaccines: PREVIX_COMBO: Pneumococcal Vaccines Early and in Combination (clinicaltrials.gov) - Oct 18, 2018
P4, N=425, Completed, Sponsor: Menzies School of Health Research
Phase classification: P=N/A --> P2 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media? (clinicaltrials.gov) - Oct 17, 2018
P=N/A, N=140, Completed, Sponsor: University of Alberta
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Jun 2018 --> Sep 2018 | Trial primary completion date: Oct 2017 --> Sep 2018
- | Trial completion: A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx (clinicaltrials.gov) - Oct 16, 2018
P1, N=29, Completed, Sponsor: Roswell Park Cancer Institute
Recruiting --> Completed | Trial completion date: Jun 2018 --> Sep 2018 | Trial primary completion date: Oct 2017 --> Sep 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Post-market Clinical Follow-up of a Magnetic Bone Conduction Implant (Cochlear Baha Attract System) (clinicaltrials.gov) - Oct 5, 2018
P=N/A, N=54, Completed, Sponsor: Cochlear Bone Anchored Solutions
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Aug 2017 --> Nov 2017
- | ketamine / Generic mfg.
Enrollment change, Trial withdrawal: Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect? (clinicaltrials.gov) - Oct 3, 2018
P=N/A, N=0, Withdrawn, Sponsor: Western Galilee Hospital-Nahariya
Active, not recruiting --> Completed | Trial completion date: Aug 2017 --> Nov 2017 N=50 --> 0 | Recruiting --> Withdrawn
- | Enrollment closed: Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss (clinicaltrials.gov) - Sep 26, 2018
P1/2, N=115, Active, not recruiting, Sponsor: Nordmark Arzneimittel GmbH & Co. KG
N=50 --> 0 | Recruiting --> Withdrawn Recruiting --> Active, not recruiting
- | Trial termination: Hereditary Deficits in Auditory Processing Leading to Language Impairment (clinicaltrials.gov) - Sep 20, 2018
P=N/A, N=875, Terminated, Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting --> Active, not recruiting Completed --> Terminated
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Effects of External Vibration on Voice Quality in Muscle Tension Dysphonia Patients and Classically Trained Singers (clinicaltrials.gov) - Sep 5, 2018
P=N/A, N=29, Completed, Sponsor: St. Michael's Hospital, Toronto
Completed --> Terminated Recruiting --> Completed | Trial completion date: Aug 2018 --> Jan 2016 | Trial primary completion date: Aug 2018 --> Jan 2016
- | emvododstat (PTC299) / PTC Therap
Enrollment change, Trial termination: PTC299 for Treatment of Neurofibromatosis Type 2 (clinicaltrials.gov) - Aug 28, 2018
P2, N=11, Terminated, Sponsor: PTC Therapeutics
Recruiting --> Completed | Trial completion date: Aug 2018 --> Jan 2016 | Trial primary completion date: Aug 2018 --> Jan 2016 N=25 --> 11 | Suspended --> Terminated
- | Trial completion, Enrollment change: Vestibular Rehabilitation and Dizziness (clinicaltrials.gov) - Aug 22, 2018
P=N/A, N=49, Completed, Sponsor: VA Office of Research and Development
N=25 --> 11 | Suspended --> Terminated Active, not recruiting --> Completed | N=97 --> 49
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Reduction of IgE Antibody in Human Allergic Subjects (clinicaltrials.gov) - Aug 21, 2018
P1, N=40, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed | N=97 --> 49 Active, not recruiting --> Completed | N=60 --> 40 | Trial completion date: Jan 2018 --> Jun 2017 | Trial primary completion date: Jan 2018 --> Jun 2017
- | NN1213 / Novo Nordisk
Trial completion: SBRCTHILARBA: Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial Asthma (clinicaltrials.gov) - Aug 16, 2018
P=N/A, N=100, Completed, Sponsor: Mahesh Bhattacharyya Homoeopathic Medical College and Hospital
Active, not recruiting --> Completed | N=60 --> 40 | Trial completion date: Jan 2018 --> Jun 2017 | Trial primary completion date: Jan 2018 --> Jun 2017 Active, not recruiting --> Completed
- | carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Trial completion date, Metastases: Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer (clinicaltrials.gov) - Aug 14, 2018
P2, N=26, Completed, Sponsor: Jonsson Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Jan 2017
- | Trial completion, Enrollment change, Trial primary completion date: Testing of a New Scale Measuring Medical Outcomes of Dysphagia (MOD) in Adult Patients With Swallowing Disorders (clinicaltrials.gov) - Aug 8, 2018
P=N/A, N=280, Completed, Sponsor: University Health Network, Toronto
Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Jan 2017 Recruiting --> Completed | N=500 --> 280 | Trial primary completion date: Dec 2016 --> Jul 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma (clinicaltrials.gov) - Aug 8, 2018
P2b, N=57, Completed, Sponsor: Laboratorios Leti, S.L.
Recruiting --> Completed | N=500 --> 280 | Trial primary completion date: Dec 2016 --> Jul 2018 Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Jun 2018
- | 5-fluorouracil / Generic mfg., cisplatin / Generic mfg., docetaxel / Generic mfg.
Trial completion date, Trial primary completion date: GORTEC-NPC2006: Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers (clinicaltrials.gov) - Aug 6, 2018
P3, N=83, Terminated, Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Jun 2018 Trial completion date: Aug 2015 --> Dec 2017 | Trial primary completion date: Aug 2015 --> Dec 2017
- | Trial primary completion date: Eustachian Tube Growth and Development (clinicaltrials.gov) - Aug 2, 2018
P=N/A, N=150, Active, not recruiting, Sponsor: University of Pittsburgh
Trial completion date: Aug 2015 --> Dec 2017 | Trial primary completion date: Aug 2015 --> Dec 2017 Trial primary completion date: Jul 2018 --> Jul 2020
- | loratadine / Generic mfg.
Trial completion, Trial completion date: Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis (clinicaltrials.gov) - Jul 18, 2018
P2, N=98, Completed, Sponsor: Zhao Hong
Trial primary completion date: Jul 2018 --> Jul 2020 Recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018
- | NN1213 / Novo Nordisk
Trial completion: CRUKD/13/001: A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma (clinicaltrials.gov) - Jul 17, 2018
P1, N=22, Completed, Sponsor: Cancer Research UK
Recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Phase classification: Early Use of Opioid in Radiation Mucositis (clinicaltrials.gov) - Jul 17, 2018
P2, N=200, Completed, Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Active, not recruiting --> Completed Not yet recruiting --> Completed | Phase classification: PN/A --> P2
- | triamcinolone acetonide topical / Generic mfg.
Phase classification: Treatment of Early Nasal Polyposis With Topical Triamcinolone (clinicaltrials.gov) - Jun 28, 2018
P1/2, N=1, Terminated, Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Not yet recruiting --> Completed | Phase classification: PN/A --> P2 Phase classification: P2 --> P1/2
- | Trial primary completion date: An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms (clinicaltrials.gov) - Jun 28, 2018
P=N/A, N=62, Recruiting, Sponsor: Virginia Commonwealth University
Phase classification: P2 --> P1/2 Trial primary completion date: Jun 2018 --> Dec 2018